Proteomic and Transcriptional Analysis of Cilia-Dependent Dopamine Receptor 1 Signaling
纤毛依赖性多巴胺受体 1 信号传导的蛋白质组学和转录分析
基本信息
- 批准号:10017361
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-12 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgonistAnxiety DisordersBardet-Biedl SyndromeBehavioralBrainBrain regionCiliaCognitive deficitsComplementCongenital neurologic anomaliesCorpus striatum structureCuesCyclic AMPDefectDevelopmentDiseaseDopamine ReceptorDrug AddictionEnvironmentEventFoundationsFunctional disorderFutureG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGenesGenetic DiseasesGenetic TranscriptionGoalsHomeostasisHuman bodyIndividualLabelLinkMalignant NeoplasmsMembraneMethodsMolecularMotor ActivityMovement DisordersMusMutateNeurologicNeuronsObesityOrganellesOutcomePathway interactionsPhysiologicalProcessProteinsProteomicsReceptor SignalingRoleSensorySignal PathwaySignal TransductionSignaling ProteinTestingTherapeuticTherapeutic AgentsTreatment EfficacyWorkappendagecell typeciliopathyexperimental studyhuman diseaseinnovationinsightnervous system disordernew therapeutic targetnovelpreventpublic health relevanceresponsesocial deficitstherapeutic targettraffickingtranscriptome sequencingtranscriptomics
项目摘要
ABSTRACT
Modulation of dopaminergic signaling has therapeutic potential for numerous neurological conditions, including
movement disorders, drug addiction, and anxiety disorders. One promising approach for modulation of
dopaminergic pathways involves targeting specific dopamine receptors to differentially regulate individual
signaling pathways. Yet, significant gaps in our understanding of dopamine receptor signaling remain and
hinder such efforts. We have discovered that dopamine receptor 1 (D1) dynamically localizes to primary cilia
on neurons in several brain regions, including the striatum. Primary cilia are cellular appendages that provide
critical sensory and signaling functions. Numerous human diseases are now known to be caused by defects in
primary cilia. Remarkably, we still know very little about how primary cilia impact neuronal function, despite the
fact that most, if not all, central neurons in the mammalian brain possess a primary cilium. Primary cilia are
restricted compartments and select G protein-coupled receptors (GPCRs), such as D1, are targeted to the
ciliary membrane in neurons. Downstream effectors of GPCR signaling also localize to neuronal cilia,
suggesting that primary cilia support specialized non-synaptic dopaminergic signaling. Indeed, we have
discovered that disrupting cilia in D1-expressing neurons results in deficient D1 signaling, as well as reduced
basal locomotor activity and obesity. In this proposal we will use cutting-edge approaches to identify the
molecular mechanisms underlying the role of cilia in D1-expressing neurons and provide critical insight into the
importance of cilia in D1 signaling. The outcomes of this work will fundamentally advance our understanding of
D1 signaling in the striatum and may implicate cilia-specific factors as novel targets for therapeutics.
摘要
多巴胺能信号传导的调节对许多神经系统疾病具有治疗潜力,包括
运动障碍、药物成瘾和焦虑症。一种有前途的方法用于调节
多巴胺能通路涉及靶向特异性多巴胺受体,以差异调节个体的多巴胺能。
信号通路然而,我们对多巴胺受体信号传导的理解仍然存在重大差距,
阻碍这种努力。我们已经发现多巴胺受体1(D1)动态定位于初级纤毛
包括纹状体在内的几个大脑区域的神经元上。初级纤毛是细胞的附属物,
关键的感觉和信号功能。现在已知许多人类疾病是由以下缺陷引起的:
初级纤毛值得注意的是,我们仍然对初级纤毛如何影响神经元功能知之甚少,
事实上,哺乳动物大脑中的大多数(如果不是全部的话)中枢神经元都具有初级纤毛。初级纤毛
限制性区室和选择G蛋白偶联受体(GPCR),如D1,靶向
神经元中的纤毛膜。GPCR信号传导的下游效应物也定位于神经元纤毛,
提示初级纤毛支持专门的非突触多巴胺能信号传导。我确已
发现破坏表达D1的神经元中的纤毛会导致D1信号传导不足,
基础运动能力和肥胖。在本提案中,我们将使用最先进的方法来确定
纤毛在表达D1的神经元中的作用的分子机制,并提供关键的洞察力,
纤毛在D1信号传导中的重要性这项工作的成果将从根本上促进我们对
纹状体中的D1信号传导,可能涉及纤毛特异性因子作为治疗的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIRK A MYKYTYN其他文献
KIRK A MYKYTYN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIRK A MYKYTYN', 18)}}的其他基金
Neuronal primary cilia in dopamine receptor 1 signaling
多巴胺受体 1 信号传导中的神经元初级纤毛
- 批准号:
8970202 - 财政年份:2015
- 资助金额:
$ 19.5万 - 项目类别:
Determinants of GPCR Ciliary Localization and Effects on Signaling
GPCR 纤毛定位的决定因素及其对信号传导的影响
- 批准号:
7527276 - 财政年份:2008
- 资助金额:
$ 19.5万 - 项目类别:
Determinants of GPCR Ciliary Localization and Effects on Signaling
GPCR 纤毛定位的决定因素及其对信号传导的影响
- 批准号:
7883343 - 财政年份:2008
- 资助金额:
$ 19.5万 - 项目类别:
Determinants of GPCR Ciliary Localization and Effects on Signaling
GPCR 纤毛定位的决定因素及其对信号传导的影响
- 批准号:
7646131 - 财政年份:2008
- 资助金额:
$ 19.5万 - 项目类别:
Determinants of GPCR Ciliary Localization and Effects on Signaling
GPCR 纤毛定位的决定因素及其对信号传导的影响
- 批准号:
8291058 - 财政年份:2008
- 资助金额:
$ 19.5万 - 项目类别:
Determinants of GPCR Ciliary Localization and Effects on Signaling
GPCR 纤毛定位的决定因素及其对信号传导的影响
- 批准号:
8109301 - 财政年份:2008
- 资助金额:
$ 19.5万 - 项目类别:
Determinants of GPCR Ciliary Localization and Effects on Signaling
GPCR 纤毛定位的决定因素及其对信号传导的影响
- 批准号:
8317818 - 财政年份:2008
- 资助金额:
$ 19.5万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别: